Marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique

Le marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et localisé, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Le marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique devrait connaître une croissance au cours de la période de prévision. Data Bridge Market Research analyse que le marché connaît une croissance de 9,5 % au cours de la période de prévision de 2022 à 2029 et devrait atteindre 179,47 millions USD d'ici 2029.

L'augmentation de la population gériatrique, la prévalence croissante des maladies chroniques telles que le cancer et le diabète, ainsi que les résultats positifs pour les patients dans un environnement domestique moins coûteux sont des facteurs majeurs à l'origine de la croissance de ce marché. Les progrès et le développement continus de la technologie et les nouvelles applications des pompes à perfusion à domicile sont des facteurs déterminants qui peuvent accroître leur utilisation. Depuis, les pompes à perfusion sont utilisées pour administrer divers médicaments afin de traiter un large éventail de maladies et d'affections, du diabète à la douleur chronique.

Les principaux facteurs susceptibles d'entraver la croissance du marché sont les fluctuations des coûts associés aux pompes à perfusion (élastomères). Avec l'augmentation de la recherche et du développement parmi les acteurs, l'investissement de capitaux dans le lancement de nouvelles pompes à perfusion et la mise à niveau de nouveaux produits, y compris le temps, peuvent résister à la croissance de ce marché. De plus, les rappels de produits liés à l'utilisation de pompes à perfusion devraient freiner la croissance du marché.

Middle East and Africa Infusion (Elastomeric) Pumps Market Definition

Elastomeric infusion pumps are also called balloon pumps which are usually used in the medical field to administer liquid drugs such as local anesthetics, analgesics, cytostatics or antibiotics. The elastomeric layer that is molded inside the pump provides the pressure required to administer the medicine. The layer is extended when the pump is filled. Elastomeric infusion pumps are single use medical devices used for drug infusion. The elastic constriction drives the liquid through the tubing and eventually through a flow restrictor out into the patient connection. An infusion pump is operated by a trained user, who programs the rate and duration of fluid delivery through a built-in software interface.

Infusion pumps offer significant advantages over manual administration of fluids, including the ability to deliver fluids in very small volumes, and the ability to deliver fluids at precisely programmed rates or automated intervals. A pressure spike that causes a higher flow rate typically occurs near the end of the infusion after a period of constant pressure. A flow restrictor (glass capillary or steel cannula), which is inserted into the elastomeric reservoir or is molded into the system's tubing, regulates the accuracy of the flow rate. Elastomeric pumps do not require any electricity and are not gravity driven. Fluid into the pump is done manually through a one-way valve by using a syringe or peristaltic repeater pump.

Middle East and Africa Infusion (Elastomeric) Pumps Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Increased incidence of CHRONIC DISEASES

The increased prevalence of chronic diseases due to the rapidly increasing population and infections can be seen. Individual risk factors, environmental factors, lack of physical activities, and human lifestyles are the major factors propelling rising incidences of diseases. The evaluation of disorders will further lead to high demand for clinical studies through different routes of administration of drug deliveries in the human body.

Cancer, thalassemia, and diuretics, among others, are some of the applications of elastomeric infusion pumps in treating chronic diseases.

The primary reason for using an elastomeric infusion pump is to assist in maintaining intravenous patency as well as aid in overcoming any potential resistance to delivering fluids, nutrients, or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers at automated intervals.

The rise in the incidence of diseases such as cancer has increased the demand for elastomeric infusion pump devices.

The increased risks of these conditions directly enhance the demand for infusion pumps required to treat such conditions. Thus, increasing chronic diseases are expected to drive the Middle East and Africa infusion (elastomeric) pump market growth.

Increased technological advancements in INFUSION (elastomeric) PUMPS

Technology advancement plays an important role in almost all processes of the healthcare industry, such as the possibility of medication errors exists due to an increase in disease burden, patient registration for data management and laboratory testing for self-care equipment, and the reach of technological innovations can be seen in healthcare with development of technologies.

The contribution of technological advancements in healthcare and clinical services is being taken out of the confines and made more accessible. Technological developments in infusion pumps result in the prevention of medication errors and the reduction of patient harm. These advancements improve clinical outcomes with patient monitoring technology to inform and guide clinicians' treatment decisions.

The commercialization of advanced technology-based infusion pump systems has increased its demand among consumers due to the increasing prevalence of chronic diseases, propelling the need for the Middle East and Africa infusion (elastomeric) pump market.

The innovation and technological advancement have upgraded the infusion (elastomeric) pump systems in all prospects, including advanced features like increased accuracy, mobility, flexibility, and different choice of smooth automatic multichannel.

Technological advancement brings many advantages to the efficiency of procedures leading to increased patient safety. Thus, growing technological advancements in infusion pump systems are expected to drive the market of Middle East and Africa infusion (elastomeric) pumps.

Increased ADOPTION OF ambulatory pumps in-home care settings

An elastomeric infusion pump is a medical device used to deliver fluids, such as medications, into a patient's body in a controlled manner. These infusion pumps are commonly used in clinical settings such as hospitals, nursing homes, and even home care settings.

Due to rising expenditure on hospitalization and the increase in the prevalence of chronic diseases, adopting ambulatory infusion pumps outside the hospital has increased. This reduces the hospital stay that surge in demand for ambulatory infusion pumps in-home care settings.

Ambulatory infusion pumps are the crucial route of drug delivery in a wide range of clinical conditions. It has a role in delivering pain control medication, TPN infusion, chemotherapy, and other infusions to patients in alternative settings.

Demand for IV infusion pumps in in-home care settings is expected to propel the market's growth, compelling the players to launch advanced infusion pumps suitable for use at home. Innovative and simplified infusion delivery systems have increased the market competition.

RESTRAINTS

FLUCTUATING cost associated with infusion (elastomeric) pumps system

The cost associated with treatment for a longer duration is quite expensive for an average-income person to afford. The utilization of critical care and intensive care unit services is increasing worldwide, and its expensive cost is a major concern in the current healthcare system.

Patients with chronic diseases are commonly required to have long hospitalizations with frequent monetarization and ventilation usage, leading to a significant amount of healthcare resources. Due to this, most patients who cannot afford a long-term stay get discharged in the initial stages of treatment. This increases the possibilities and susceptibilities for new complications in infections which demands additional healthcare resources and treatment.

The high cost of the treatment is due to the various checkpoints of the treatment along with the use of high-tech modalities to perform such treatment procedures.

The hospital care further adds to the cost of the infusion pump interventions. As the cost of innovative and advanced infusion pumps is high, the cost of the treatment proportionally gets escalated, due to which price associated with the use of the infusion pump systems is expected to restrain the Middle East and Africa trauma fixation market growth.

The fluctuating cost of infusion pumps, which increases or decreases the cost of drug therapies, is expected to hinder the market growth for infusion (elastomeric) pumps.

Side-effects of infusion (elastomeric) pumps system

The rising use of infusion pumps with technological advancements has become standard practice in hospitals to administer critical fluids to patients. However, there are still limited research studies for reducing errors and improving infusion pump use that lead to adverse events in the system. The various problems associated with it can be human errors.

However, the variety of risks and health complications associated with infusion (elastomeric) pumps and the need for further surgical intervention to fix some of them are expected to hamper their demand in the market. Thus, the health complications associated with infusion pumps are expected to restrain the Middle East and Africa infusion (elastomeric) pump market.

STRINGENT GOVERNMENT REGULATION

The concerns regarding the efficacy and safety of products have caused most governments to develop regulatory agencies and policies to look after the development of new medical devices. The use of medical devices can be done after passing stringent regulatory standards, which ensure the devices are safe, well-studied, and has no adverse reactions.

The recent guidelines and the amendment have adequate guidance for manufacturers. International regulations such as food drugs and administration play a major role in the new launch of the product into the market. Thus, it is expected to act as a major restraint on the market

The regulatory requirements that medical devices manufacturers of resuscitators present in the U.S. market must comply with are the followings: medical device listing, Quality System (QS) regulation, establishment registration, Investigational Device Exemption (IDE) for clinical studies, Medical Device Reporting (MDR) and Labelling requirements, among others.

Some special controls also include implementing post-marketing surveillance Middle East and Africasures, guidance documents, adherence to performance standards, and special labeling.

Thus, stringent government regulations on new products and instrument approval are expected to impact the growth of the Middle East and Africa infusion pumps (elastomeric) market.

OPPORTUNITIES

STRATEGIC INITIATIVES BY THE MARKET PLAYERS

The increased burden of various types of cancers like lymphoma in humans across the regions, coupled with the increase in population, has created more demand for the development of infusion pumps for applications. The main aim is to improve the infusion of required medications, nutrients, and liquid foods for patients in both acute and critical stages of the disease. Major market players are focusing on filling the demands of human healthcare professionals and spending quite a noticeable amount for better products like specific infusion pumps with more advanced technologies for convenient human use.

These strategic initiatives by the market players, including exhibitions, conferences, focused segment product launches, and certifications, are helping them expand and enhance the company's product portfolio, ultimately leading to more revenue generation. Hence these strategic initiatives by the market players are acting as an opportunity that is helping them to drive the infusion (elastomeric) pumps market in the Middle East and Africa region.

RISING HEALTHCARE EXPENDITURE

The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization for the health system. In particular, there is a strong association between the whole income level of a country and how much the country's population spends on health care.

Healthcare expenditure has increased across developed, and emerging countries as the disposable income of people are growing. The more money is spent on healthcare, the healthier a country's population is. Moreover, to accomplish the population requirements, government bodies and healthcare organizations in different regions are taking the initiative to accelerate healthcare expenditure. Therefore, the rise in healthcare expenditure simultaneously helps healthcare organizations and government bodies to increase healthcare management services in various aspects.

Growing healthcare expenditure is expected to increase the availability of infusion pumps for better patient treatment with fewer human medical errors. Hence, the massive healthcare expenditure is a favorable factor and is expected to create a significant opportunity for the growth of The Middle East and Africa infusion (elastomeric) pump market.

Rising Government Initiatives toward Safety

Increasing initiatives of many institutes, organizations, and associations to mend elastomeric infusion pumps and address safety concerns will increase the market growth. Additionally, growing aneness regarding mitigating the risks associated with using existing infusion pumps by hospital staff, administrators, and home users. Furthermore, regulatory approvals and support with funding will boost the demand growth of healthcare and medical device industries.

Rising government initiatives toward safety help cover the population's healthcare needs and are expected to create a significant opportunity for the Middle East and Africa infusion (elastomeric) pump market in the forecast period.

RIsing implementation of Small hospitals and clinics

Small hospitals and clinics are where patients are treated and mild surgeries are performed, but patients are not retained overnight, whereas small hospitals provide surgery, nursery care, and overnight treatments if required. Due to rising populations in African countries, there is a huge demand for medical care systems. During this covid-19 pandemic, people fear that health services have been partially or completely disrupted in many countries. More than half (53%) of the countries surveyed have partially or completely disrupted services for hypertension treatment; 49% for treatment for diabetes and diabetes-related complications; 42% for cancer treatment, and 31% for cardiovascular emergencies.

As there is a high requirement for medical services for the African population, governments are increasing their investment in small hospitals and clinic practices, thereby improving the growth of the Infusion (elastomeric) pump market.

CHALLENGES

product recalls

Infusion pump errors and flaws in their design can harm patients because the devices administer critical fluids, including insulin, antibiotics, and chemotherapy drugs. For this reason, most infusion pumps have extensive safety features designed to minimize the risk of harm from user error and device malfunction. International harmonization, along with frequent product inspections, is set to define the regulatory landscape for elastomeric infusion pumps. Device manufacturers are expected to invest more in better product designs to minimize the probability of product recalls and adverse impacts on patient safety.

Rising product recalls from the market due to their design flaws may be causing the side effects associated with the material for the elastomeric infusion pump to act as a major challenge hampering the growth of the Middle East and Africa infusion (elastomeric) pump market.

rising competition between market players

There is an increase in human and animal healthcare management in developed and underdeveloped countries. Rising incidences of cancer cases in the young generation and in the geriatric population has boosted the demand for infusion pumps and related products in clinics, hospitals, and home care settings. The rising research activities have implemented many novel pumps for convenient application. Many small companies have initiated highly advanced multichannel pumps with high lifetime and single-use disposable products due to the high demand for these advanced products. These companies are exhibiting their products in numerous fair shows gaining more popularity and a huge customer basis, thereby being a bottleneck for other major players.

Thus, increasing competition is a major challenge hampering the growth of the Middle East and Africa infusion (elastomeric) pump market.

RECENT DEVELOPMENTS

• In August 2022, B. Braun SE presented its engagement in Africa at a citizens' festival. Under the motto "Sharing Expertise with Africa," the focus will be on the company's various activities to build infrastructure and healthcare in Africa. This will help in developing the company's image across the country.
• In August 2022, Baxter International Inc announced the U.S. Food and Drug Administration (FDA) clearance of the Novum IQ Syringe Infusion Pump with Dose IQ Safety Software, ensuring the correct medications and fluids are delivered to the patient. This help in expanding the product and services access to healthcare in emerging and developed countries portfolio the company.

Middle East and Africa Infusion (Elastomeric) Pumps Market Scope

Middle East and Africa infusion (elastomeric) pumps market is segmented into product type, route of administration, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

BY PRODUCT TYPE

• ELASTOMERIC INFUSION PUMPS
• ACCESSORIES AND CONSUMABLES

On the basis of product type, the Middle East and Africa infusion (elastomeric) pumps market is segmented into elastomeric infusion pumps, and accessories and consumables.

BY ROUTE OF ADMINISTRATION

• SUBCUTANEOUS
• INTRAVENOUS (IV)
• EPIDURAL
• INTRAMUSCULAR

On the basis of route of administration, the Middle East and Africa infusion (elastomeric) pumps market is segmented into subcutaneous, intravenous (IV), epidural and intramuscular.

BY APPLICATION

• PAIN MANAGEMENT
• ANTIBIOTIC/ANTIVIRAL THERAPY
• CHEMOTHERAPY
• THALASSEMIA TREATMENT
• DIURETICS TREATMENT
• LONG TERM INFUSION TREATMENT
• OTHER APPLICATIONS

On the basis of application, the Middle East and Africa infusion (elastomeric) pumps market is segmented into pain management, antibiotic/antiviral therapy, chemotherapy, thalassemia treatment, diuretics treatment, long term infusion treatment and other applications.

 BY END USER

• HOSPITALS
• HOMECARE SETTINGS
• AMBULATORY SURGICAL CENTERS
• ACADEMIC AND RESEARCH INSTITUTES
• SPECIALTY CLINICS
• OTHERS

On the basis of end user, the Middle East and Africa infusion (elastomeric) pumps market is segmented into hospitals, homecare settings, ambulatory surgical centers, academic and research institutes, specialty clinics and others.

BY DISTRIBUTION CHANNEL

• DIRECT TENDER
• RETAIL SALES
• ONLINE SALES
• OTHERS

On the basis of distribution channel, the Middle East and Africa infusion (elastomeric) pumps market is segmented into direct tender, retail sales, online sales and others.

Middle East and Africa Infusion (Elastomeric) Pumps Market Regional Analysis/Insights

The Middle East and Africa infusion (elastomeric) pumps market is analyzed and market size information is provided by product type, route of administration, application, end user and distribution channel.

The countries covered in this market report are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.

In 2022, the Middle East and Africa infusion (elastomeric) pumps market is expected to grow due to several reasons such as increasing incidence of chronic disease and growing technological advancements in infusion pumps systems.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, les actes réglementaires et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques du Moyen-Orient et d'Afrique et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique

Le paysage concurrentiel du marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et la portée du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise sur le marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique.

Les principaux acteurs du marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique sont B. Braun SE, Epic Medical, ICU Medical, Inc, Werefen, Nipro, AVNS et Baxter, entre autres.

Méthodologie de recherche : Marché des pompes à perfusion (élastomères) au Moyen-Orient et en Afrique

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. En outre, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. La principale méthodologie de recherche utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement de l'entreprise, l'analyse des parts de marché des entreprises, les normes de mesure, l'Amérique du Nord par rapport aux régions et l'analyse des parts des fournisseurs. Veuillez demander un appel d'analyste en cas de demande de renseignements supplémentaires.

SKU-69430